TY  - JOUR
AU  - Zitricky, Frantisek
AU  - Försti, Asta
AU  - Hemminki, Akseli
AU  - Hemminki, Otto
AU  - Hemminki, Kari
TI  - Conditional Survival in Prostate Cancer in the Nordic Countries Elucidates the Timing of Improvements.
JO  - Cancers
VL  - 15
IS  - 16
SN  - 2072-6694
CY  - Basel
PB  - MDPI
M1  - DKFZ-2023-01736
SP  - 4132
PY  - 2023
N1  - #LA:C020#
AB  - The incidence of prostate cancer (PC) increased vastly as a result of prostate-specific antigen (PSA) testing. Survival in PC improved in the PSA-testing era, but changes in clinical presentation have hampered the interpretation of the underlying causes.We analyzed survival trends in PC using data from the NORDCAN database for Denmark (DK), Finland (FI), Norway (NO) and Sweden (SE) by analyzing 1-, 5- and 10-year relative survival and conditional relative survival over the course of 50 years (1971-2020).In the pre-PSA era, survival improved in FI and SE and improved marginally in NO but not in DK. PSA testing began toward the end of the 1980s; 5-year survival increased by approximately 30
KW  - PSA screening (Other)
KW  - periodic survival (Other)
KW  - prognosis (Other)
KW  - treatment (Other)
LB  - PUB:(DE-HGF)16
C6  - pmid:37627160
C2  - pmc:PMC10453103
DO  - DOI:10.3390/cancers15164132
UR  - https://inrepo02.dkfz.de/record/282352
ER  -